½ÃÀ庸°í¼­
»óǰÄÚµå
1813960

³»½Ã°æ Àçó¸® ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ - Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2033³â)

Endoscope Reprocessing Market Size, Share & Trends Analysis Report By Product (High-Level Disinfectants & Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors), By End-use, By Region, And Segment Forecasts, 2025 - 2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

³»½Ã°æ Àçó¸® ½ÃÀå °³¿ä

¼¼°èÀÇ ³»½Ã°æ Àçó¸® ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 17¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2025-2033³â CAGR 6.64%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2033³â¿¡´Â 30¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿À¿°µÈ ³»½Ã°æÀ¸·Î ÀÎÇÑ °¨¿° Áõ°¡ ¹× Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ°¡ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

2024³â 1¿ù¿¡ ¹ßÇ¥µÈ '³»½Ã°æÀû ¿ªÇ༺ ´ã°ü Ãé°ü Á¶¿µÀ» À§ÇÑ ½ÃÆÇÀÇ ´Üȸ »ç¿ë ½ÊÀÌÁöÀå ³»½Ã°æÀÇ Ä«´©·¹À̼Ƿü°ú ±â¼úÀû ¼º´É Æò°¡-ü°èÀû ¸®ºä¿Í ¸ÞŸ ºÐ¼®'À̶ó°í ÇÏ´Â ¿¬±¸¿¡ µû¸£¸é ½ÊÀÌÁöÀå ³»½Ã°æ°ú °ü·ÃµÈ °¨¿°ÁõÀÇ ¹üÀ§´Â 0.4%¿¡¼­ 1%¿´½À´Ï´Ù.

¸¸¼º Æó»ö¼º ÆóÁúȯ(COPD)À» Áß½ÉÀ¸·Î È£Èí±â Áúȯ ºÎ´ã Áõ°¡°¡ ½ÃÀåÀÇ ±Þ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. JAMA NetworkÀÇ º¸°í¼­¿¡ µû¸£¸é 2020³â COPDÀÇ ¼¼°è À¯º´·üÀº 10.6%·Î ÃßÁ¤µÇ¸ç, ÀÌ´Â ³²³à¸¦ ºÒ¹®Çϰí 4¾ï 8,000¸¸ Áõ·Ê¿¡ ÇØ´çÇÕ´Ï´Ù. 2050³â¿¡´Â 1¾ï 1,200¸¸ ¸í Áõ°¡ÇÑ 5¾ï 9,200¸¸ ¸íÀÌ µÉ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ÀÌ´Â Àα¸ÀÇ 9.5%¿¡ ÇØ´çÇÕ´Ï´Ù. 2020-2050³â 23.3%°¡ »ó´ëÀûÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °á°úÀûÀ¸·Î Áúº´ÀÇ Á¶±â Áø´Ü°ú Ä¡·á¸¦ À§ÇØ ³»½Ã°æ Àåºñ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý ¹× ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ³»½Ã°æ Àçó¸® ½ÃÀåÀÇ º¯¼ö, µ¿Çâ ¹× ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • º¸Á¶ ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ³»½Ã°æ Àçó¸® : ½ÃÀå ºÐ¼® µµ±¸
    • ¾÷°è ºÐ¼®-Porter's Five Forces ºÐ¼®
    • PESTLE ºÐ¼®
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©

Á¦4Àå ³»½Ã°æ Àçó¸® ½ÃÀå ºÎ¹® ºÐ¼® : Á¦Ç°º°(2021-2033³â)

  • Á¤ÀÇ¿Í ¹üÀ§
  • ½ÃÀå Á¡À¯À² ºÐ¼® : Á¦Ç°º°(2024³â, 2033³â)
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ³»½Ã°æ Àçó¸® ½ÃÀå : Á¦Ç°º°(2021-2033³â)
  • °í¼öÁØ ¼Òµ¶Á¦ ¹× ½ÃÇèÁö
    • °í¼öÁØ ¼Òµ¶Á¦ ¹× ½ÃÇèÁö ½ÃÀå Ãß°è ¹× ¿¹Ãø(2021-2033³â)
  • ¼¼Á¦ ¹× ¹°Æ¼½´
    • ¼¼Á¦ ¹× ¿ÍÀÌÇÁ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2021-2033³â)
  • ÀÚµ¿ ³»½Ã°æ Àçó¸® ÀåÄ¡(AER)
    • ÀÚµ¿ ³»½Ã°æ Àçó¸® ÀåÄ¡(AER) ½ÃÀå Ãß°è ¹× ¿¹Ãø(2021-2033³â)
  • À¯Çü
    • À¯Çü ½ÃÀå Ãß°è ¹× ¿¹Ãø(2021-2033³â)
  • È޴뼺
    • È޴뼺 ½ÃÀå Ãß°è ¹× ¿¹Ãø(2021-2033³â)
  • ³»½Ã°æÀÇ °ÇÁ¶, º¸°ü ¹× ¼ö¼Û ½Ã½ºÅÛ
    • ³»½Ã°æÀÇ °ÇÁ¶, º¸°ü ¹× ¼ö¼Û ½Ã½ºÅÛ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2021-2033³â)
  • ±âŸ
    • ±âŸ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2021-2033³â)

Á¦5Àå ³»½Ã°æ Àçó¸® ½ÃÀå ºÎ¹® ºÐ¼® : ÃÖÁ¾ ¿ëµµº°(2021-2033³â)

  • Á¤ÀÇ ¹× ¹üÀ§
  • ½ÃÀå Á¡À¯À² ºÐ¼® : ÃÖÁ¾ ¿ëµµº°(2024³â, 2033³â)
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ³»½Ã°æ Àçó¸® ½ÃÀå : ÃÖÁ¾ ¿ëµµº°(2021-2033³â)
  • º´¿ø
    • º´¿ø ½ÃÀå Ãß°è ¹× ¿¹Ãø(2021-2033³â)
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
    • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ½ÃÀå Ãß°è ¹× ¿¹Ãø(2021-2033³â)

Á¦6Àå ³»½Ã°æ Àçó¸® ½ÃÀå ºÎ¹® ºÐ¼® : Áö¿ªº°(2021-2033³â)

  • ½ÃÀå Á¡À¯À² ºÐ¼® : Áö¿ªº°(2024³â, 2033³â)
  • ½ÃÀå ´ë½Ãº¸µå : Áö¿ªº°
  • ½ÃÀå ÇöȲ : Áö¿ªº°
  • ³»½Ã°æ Àçó¸® ½ÃÀå Á¡À¯À² : Áö¿ªº°(2024³â, 2033³â)
  • ºÏ¹Ì
    • ºÏ¹ÌÀÇ ³»½Ã°æ Àçó¸® ½ÃÀå(2021-2033³â)
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • À¯·´ÀÇ ³»½Ã°æ Àçó¸® ½ÃÀå(2021-2033³â)
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³ë¸£¿þÀÌ
    • ½º¿þµ§
    • µ§¸¶Å©
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Äí¿þÀÌÆ®

Á¦7Àå °æÀï ±¸µµ

  • ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷¿¡ ÀÇÇÑ ÃÖ±ÙÀÇ µ¿Çâ ¹× ¿µÇ⠺м®
  • ±â¾÷ ºÐ·ù
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Cantel Medical
    • Fortive Corporation(Advanced Sterilization Products)
    • Olympus Corporation
    • Ecolab
    • Getinge AB
    • STERIS
    • Steelco SpA
    • ARC Group of Companies Inc.
    • Metrex Research, LLC.
    • Shinva Medical Instrument Co. Ltd.
    • Belimed
AJY

Endoscope Reprocessing Market Summary

The global endoscope reprocessing market size was estimated at USD 1.71 billion in 2024 and is projected to reach USD 3.02 billion by 2033, growing at a CAGR of 6.64% from 2025 to 2033. Growing infections caused by contaminated endoscopes and increasing preference for minimally invasive surgery are anticipated to boost market growth.

According to a study called "Cannulation rates and technical performance evaluation of commercially available single-use duodenoscopes for endoscopic retrograde cholangiopancreatography: A systematic review and meta-analysis" published in January 2024, the range of infections related to duodenoscopes was between 0.4% to 1%.

The increasing respiratory disease burden, mainly chronic obstructive pulmonary disorders (COPD), is driving market growth rapidly. According to the JAMA Network report, the global prevalence of COPD was estimated to be 10.6% in 2020, which equals 480 million cases across both genders. The report shows that cases are expected to rise by 112 million to 592 million by 2050, which is 9.5% of the population. This indicates a relative increase of 23.3% from 2020 to 2050. As a result, the demand for endoscopic devices is increasing significantly for early disease diagnosis and treatment, which is further propelling the market growth.

Global Endoscopes Reprocessing Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segment from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the endoscope reprocessing market report based on product, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • High-Level Disinfectants and Test Strips
  • Detergents and Wipes
  • Automated Endoscope Reprocessors
    • By Type
    • Single basin
    • Double basin
    • By Portability
    • Standalone
    • Portable
  • Endoscope Drying, Storage, and Transport Systems
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Europe
  • Germany
    • UK
    • Spain
    • Italy
    • France
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Endoscope Reprocessing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing preference for minimally invasive surgery
      • 3.2.1.2. Growing number of infections caused by contaminated endoscopes
      • 3.2.1.3. Increasing respiratory disease burden
      • 3.2.1.4. Technological advancements in endoscope reprocessing
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Rising shift towards disposable endoscopes
      • 3.2.2.2. Product recalls
  • 3.3. Endoscope reprocessing: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Regulatory Framework

Chapter 4. Endoscope Reprocessing Market Segment Analysis, By Product, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global endoscope reprocessing Market, by product, 2021 - 2033
  • 4.5. High-Level Disinfectants and Test Strips
    • 4.5.1. High-level disinfectants and test strips market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Detergents and wipes
    • 4.6.1. Detergents and wipes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Automated Endoscope Reprocessors (AERs)
    • 4.7.1. Automated endoscope reprocessors (AERs) market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.2. Type
    • 4.7.3. Type market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.7.3.1. Single basin
        • 4.7.3.1.1. Single basin market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.7.3.2. Double basin
        • 4.7.3.2.1. Double basin market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.4. Portability
    • 4.7.5. Portability market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.7.5.1. Standalone
        • 4.7.5.1.1. Standalone market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.7.5.2. Portable
        • 4.7.5.2.1. Portable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. Endoscope Drying, Storage, and Transport Systems
    • 4.8.1. Endoscope drying, storage, and transport systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Endoscope Reprocessing Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. End Use Market Share Analysis, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global endoscope reprocessing Market, by end use, 2021 - 2033
  • 5.5. Hospitals
    • 5.5.1. Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Ambulatory Surgical Centers (ASCs)
    • 5.6.1. Ambulatory surgical centers (ASCs) market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Endoscope Reprocessing Market Segment Analysis, By Region, By Product, By End Use, 2021 - 2033 (USD Million)

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Regional Market Snapshot
  • 6.4. Endoscope Reprocessing Market Share by Region, 2024 & 2033:
  • 6.5. North America
    • 6.5.1. North America endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. U.S. endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Canada endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Mexico endoscope reprocessing market, 2021 - 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. Europe endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.6.2. UK
      • 6.6.2.1. UK endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Germany endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.6.4. France
      • 6.6.4.1. France endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Italy endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Spain endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.6.7. Norway
      • 6.6.7.1. Norway endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Sweden endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.6.9. Denmark
      • 6.6.9.1. Denmark endoscope reprocessing market, 2021 - 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Japan endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. China endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. India endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Australia endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. South Korea endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Thailand endoscope reprocessing market, 2021 - 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Brazil endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Argentina endoscope reprocessing market, 2021 - 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. South Africa endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Saudi Arabia endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. UAE endoscope reprocessing market, 2021 - 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Kuwait endoscope reprocessing market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Profiles
    • 7.3.1. Cantel Medical
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Product benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. Fortive Corporation (Advanced Sterilization Products)
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Olympus Corporation
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Ecolab
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Getinge AB
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. STERIS
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Steelco S.p.A
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. ARC Group of Companies Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Metrex Research, LLC.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Shinva Medical Instrument Co. Ltd.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Belimed
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦